An Analytical Reference Standard
Related Products
Metabolite(s)
37339nor-Orphine
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Technical Information
Formal Name
1-(1-(1-(4-iodophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one
Molecular Formula
C20H22IN3O
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 2 mg/mlDMSO: 1 mg/ml
SMILES
CC(C1=CC=C(I)C=C1)N2CCC(N3C(NC4=C3C=CC=C4)=O)CC2
InChi Code
InChI=1S/C20H22IN3O/c1-14(15-6-8-16(21)9-7-15)23-12-10-17(11-13-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-9,14,17H,10-13H2,1H3,(H,22,25)
InChi Key
JSAXFVKTSYWRTR-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Cayman Spectral Library

    Our free, searchable, GC-MS spectral database contains 70eV EI mass spectral data of 2,000+ of Cayman’s forensic drug standards.

    DOWNLOAD THE DATABASE
    Product Description

    Iodorphine (Item No. 37062) is an analytical reference standard categorized as an opioid.1 Iodorphine induces antinociception and respiratory depression in mice, which can be reversed by naloxone (Item Nos. ISO60191 | 15594). This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Vandeputte, M.M., Bilel, S., Tirri, M., et alElucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization. Neuropharmacology 260, 110113 (2024).

    Product Citations

    Lenzi, M., Gasperini, S., Bilel, S., et alNew synthetic opioids: What do we know about the mutagenicity of brorphine and its analogues? Int. J. Mol. Sci. 26(11), 5084 (2025).